FDA Approves New Drug to Treat Alzheimer’s
TUESDAY, July 2, 2024 (HealthDay News) — A new drug to treat Alzheimer’s disease was approved by the U.S. Food and Drug Administration on Tuesday. In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it alsoContinue Reading